Archive - December 2018
Novartis Announces FDA Filing Acceptance and Priority Review of AVXS-101, a One-Time Treatment Designed to Address the Genetic Root Cause of SMA Type 1
New Barhemsys PDUFA Date Confirmed for 5 May 2019
Intra-Cellular Therapies Announces FDA Acceptance of New Drug Application for Lumateperone for the Treatment of Schizophrenia
UroGen Pharma Initiates Rolling Submission of New Drug Application (NDA) for UGN-101 for the Treatment of Low-Grade Upper Tract Urothelial Cancer
Alkermes and Biogen Announce Submission of a New Drug Application to U.S. Food and Drug Administration for Diroximel Fumarate in Multiple Sclerosis
5 Health Benefits Of Eating Hazelnuts
Top Death Causes For US Kids: Car Accidents, Guns
Wearing Contact Lenses While Sleeping? Why That’s A Bad Idea
